Together with collaborators, we have reported that the EYA4 gene is hypermethylated in the first intronexon junction (15), and possibly over-expressed in triple-negative breast cancer patients, which correlates with publicly available TCGA dataset that shows amplification as the most common alteration in breast cancer patients. The gene discussed is EYA4; the disease is triple-negative breast carcinoma.